Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients

Gastroenterology

Volumn 149, Issue 2, 2015, Pages 379-388

  Lassailly, Guillaume ^a,b   Caiazzo, Robert ^a,c   Buob, David ^a   Pigeyre, Marie ^d   Verkindt, Hélène ^a   Labreuche, Julien ^a   Raverdy, Violeta ^a   Leteurtre, Emmanuelle ^a   Dharancy, Sébastien ^a,b   Louvet, Alexandre ^a,b   Romon, Monique ^d   Duhamel, Alain ^a   Pattou, François ^a,c   Mathurin, Philippe ^a,b  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE LILLE   (France)

^c NONE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

LAGB; NAFLD; Obesity; Weight Reduction Surgery

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BARIATRIC SURGERY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL STUDY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTRIC BANDING; HISTOLOGY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEVE GASTRECTOMY; STOMACH BYPASS; WEIGHT CHANGE; BLOOD; FRANCE; GASTRIC BYPASS SURGERY; LIVER; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; ALANINE TRANSAMINASE; BARIATRIC SURGERY; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; FRANCE; GAMMA-GLUTAMYLTRANSFERASE; GASTRIC BYPASS; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84938070225     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.04.014     Document Type: Article

References (38)

1. J.D. Browning, L.S. Szczepaniak, R. Dobbins, and et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
2. L.A. Adams, J.F. Lymp, J. St Sauver, and et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121
3. S. Romeo, J. Kozlitina, C. Xing, and et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
4. C.A. Matteoni, Z.M. Younossi, T. Gramlich, and et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
5. P. Bedossa, C. Poitou, N. Veyrie, and et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients Hepatology 56 2012 1751 1759
6. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, and et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
7. D.E. Kleiner, E.M. Brunt, M. Van Natta, and et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
8. E.M. Brunt, D.E. Kleiner, L.A. Wilson, and et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings Hepatology 53 2011 810 820
9. N. Chalasani, Z. Younossi, J.E. Lavine, and et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 142 2012 1592 1609
10. S.A. Harrison, W. Fecht, E.M. Brunt, and et al. Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial Hepatology 49 2009 80 86
11. A.J. Sanyal, N. Chalasani, K.V. Kowdley, and et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
12. G.P. Aithal, J.A. Thomas, P.V. Kaye, and et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis Gastroenterology 135 2008 1176 1184
13. J.D. Lewis, A. Ferrara, T. Peng, and et al. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study Diabetes Care 34 2011 916 922
14. E.A. Klein, I.M. Thompson Jr., C.M. Tangen, and et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA 306 2011 1549 1556
15. G. Mingrone, S. Panunzi, A. De Gaetano, and et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes N Engl J Med 366 2012 1577 1585
16. P.R. Schauer, D.L. Bhatt, J.P. Kirwan, and et al. Bariatric surgery versus intensive medical therapy for diabetes - 3-year outcomes N Engl J Med 370 2014 2002 2013
17. P.R. Schauer, S.R. Kashyap, K. Wolski, and et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes N Engl J Med 366 2012 1567 1576
18. G. Lassailly, R. Caiazzo, F. Pattou, and et al. Bariatric surgery for curing NASH in the morbidly obese? J Hepatol 58 2013 1249 1251
19. P. Mathurin, A. Hollebecque, L. Arnalsteen, and et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease Gastroenterology 137 2009 532 540
20. N.C. Chavez-Tapia, F.I. Tellez-Avila, T. Barrientos-Gutierrez, and et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients Cochrane Database Syst Rev 2010 CD007340
21. F. Eriksson Biliointestinal bypass Int J Obes 5 1981 437 447
22. L. Sjostrom Surgical intervention as a strategy for treatment of obesity Endocrine 13 2000 213 230
23. A. Katz, S.S. Nambi, K. Mather, and et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
24. P. Mathurin, F. Gonzalez, O. Kerdraon, and et al. The evolution of severe steatosis after bariatric surgery is related to insulin resistance Gastroenterology 130 2006 1617 1624
25. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293
26. T.A. Wadden, S. Volger, D.B. Sarwer, and et al. A two-year randomized trial of obesity treatment in primary care practice N Engl J Med 365 2011 1969 1979
27. J.B. Dixon, P.S. Bhathal, N.R. Hughes, and et al. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss Hepatology 39 2004 1647 1654
28. S. Klein, B. Mittendorfer, J.C. Eagon, and et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease Gastroenterology 130 2006 1564 1572
29. K.B. Barker, N.A. Palekar, S.P. Bowers, and et al. Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery Am J Gastroenterol 101 2006 368 373
30. R.H. Freire, M.C. Borges, J.I. Alvarez-Leite, and et al. Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass Nutrition 28 2012 53 58
31. H. Buchwald, Y. Avidor, E. Braunwald, and et al. Bariatric surgery: a systematic review and meta-analysis JAMA 292 2004 1724 1737
32. S. Pham, A. Gancel, M. Scotte, and et al. Comparison of the effectiveness of four bariatric surgery procedures in obese patients with type 2 diabetes: a retrospective study J Obes 2014 2014 638203
33. S.A. Brethauer, A. Aminian, H. Romero-Talamas, and et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus Ann Surg 258 2013 628 636 discussion 636-627
34. R. Caiazzo, G. Lassailly, E. Leteurtre, and et al. Roux-en-Y Gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study Ann Surg 260 2014 893 899
35. J. Henao-Mejia, E. Elinav, C. Jin, and et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185
36. M.P. Hocking, M.C. Duerson, J.P. O'Leary, and et al. Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases N Engl J Med 308 1983 995 999
37. P. Benotti, G.C. Wood, D.A. Winegar, and et al. Risk factors associated with mortality after Roux-en-Y gastric bypass surgery Ann Surg 259 2014 123 130
38. L. Sjostrom, K. Narbro, C.D. Sjostrom, and et al. Effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 357 2007 741 752